Subhashis Banerjee - 15 Feb 2026 Form 4 Insider Report for Artiva Biotherapeutics, Inc. (ARTV)

Role
Chief Medical Officer
Signature
/s/ Andrew Cronauer, Attorney-in-Fact
Issuer symbol
ARTV
Transactions as of
15 Feb 2026
Net transactions value
$0
Form type
4
Filing time
18 Feb 2026, 18:48:47 UTC
Previous filing
25 Apr 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Banerjee Subhashis Chief Medical Officer C/O ARTIVA BIOTHERAPEUTICS, INC., 5505 MOREHOUSE DRIVE, SUITE 100, SAN DIEGO /s/ Andrew Cronauer, Attorney-in-Fact 18 Feb 2026 0002065633

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARTV Common Stock Award $0 +102,000 +204% $0.000000 152,000 15 Feb 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan.